page_banner

labarai

  • Targeted N vs. S protein in COVID-19 Antibody Testing

    Abubuwan da aka yi niyya N vs. S a cikin Gwajin rigakafin Cutar COVID-19

    Abubuwan da aka yi niyya na N vs. S a cikin Gwajin Kwayoyin cuta na COVID-19 Duk cikin cutar ta COVID-19, masu bincike sun yi aiki tuƙuru don fahimtar martanin rigakafin ɗan adam ga SARS-CoV-2, gami da tsawon lokaci da matakin kariyar da ƙwayoyin rigakafi za su iya bayarwa game da sake dawowa. -kamuwa da cuta.Da dama...
    Kara karantawa
  • This Winter’s Flu Season Epidemic Has Started – What We Know So Far and What Needs To Be Done To Control It

    Wannan Cutar ta Murar lokacin sanyi ta Fara - Abin da Muka Sani Ya zuwa yanzu da Abin da Ya Kamata A Yi Don Sarrafa shi.

    Wannan Annobar Cutar Murar Lokacin hunturu ta Fara - Abin da Muka Sani Ya zuwa yanzu da Abin da Ya Kamata Ayi Domin Yaƙarta A cikin makon da ya fara ranar 13 ga Disamba adadin masu kamuwa da mura (wanda kwayar cutar mura ta haifar) da aka gano a yankin Turai na WHO ya fi abin da muka samu. yawanci ina tsammanin zan samu...
    Kara karantawa
  • First Omicron Report of A Real World Infection: Highly Contagious with Flu-Like Symptoms

    Rahoton Omicron na Farko na Cutar Kwayar cuta ta Duniya: Mai Yaɗuwa sosai tare da Alamomin Flu-Kamar

    Rahoton Omicron na Farko na Cutar da Duniya ta Haƙiƙa: Mai Yaɗuwa da Alamun Flu-Kamar Alamun SARS-CoV-2 Omicron bambance-bambancen yana saita sabon bullar annobar COVID-19 a duniya.Nazarin cututtukan cututtukan fata shine tushen don bayyana kamuwa da cuta, tserewar rigakafi da tsananin cutar ...
    Kara karantawa
  • GENESIS products continue to detect SARS-CoV-2 mutant strain Omicron

    Kayayyakin GENESIS sun ci gaba da gano nau'in mutant na SARS-CoV-2 Omicron

    A ranar 26 ga Nuwamba WHO ta sanya B.1.1.529 bambancin damuwa (VOC) saboda shaidar farko na wani canji mai lahani a cikin cututtukan COVID-19.A matsayin VOC, an kira shi Omicron.Omicron yana da adadi mai yawa na maye gurbin da suka haɗa da fiye da 30 maye gurbi na furotin mai karu.Wasu maye gurbi...
    Kara karantawa
  • Use of Antigen-Detection Rapid Diagnostic Testing on COVID-19

    Amfani da Antigen-Gano Gwajin Gano Mai Sauri akan COVID-19

    Amfani da Gwajin Gano Mai Saurin Ganewa Kan COVID-19 Menene amfanin gwajin saurin gano antigen akan COVID-19? WHO ta ba da shawarar cewa a gwada duk wasu maganganun da ake zargi don SARS-CoV-2.Gwajin gano maganin antigen yana amfani da samfurin numfashi na sama ko yau don gwadawa ...
    Kara karantawa
  • Farawa COVID-19 jimlar IVD MAGANIN

    Farawa COVID-19 IVD TOTAL SOLUTION A Duniya, daga 4:08pm CET, 9 Disamba 2021, an sami 267,184,623 da aka tabbatar sun kamu da COVID-19, gami da mutuwar 5,277,327, an ruwaito ga WHO.Ya zuwa ranar 8 ga Disamba, 2021, an yi alluran rigakafi guda 8,158,815,265.Mu Genesis kaddamar da mu...
    Kara karantawa
  • MEDICA |GENESIS Ya Halarci Nunin tare da Maganin Flu&COVID-19

    MEDICA |GENESIS Ya Halarci Nunin Nunin tare da Flu&COVID-19 Solutions Hangzhou Genesis Biodetection & Biocontrol Co., Ltd. ya halarci taron 53rd MEDICA 2021 na Duniya don Magunguna a DÜSSELDORF, GERMANY tsakanin Nuwamba 15th-18th.Game da MEDICA: An Kafa "MEDICA" a cikin 1968, wani ...
    Kara karantawa
  • Respiratory Care Week 2021

    Makon Kulawa da Numfashi 2021

    Gwajin Rapid na KaiBiLiTM RSV Antigen Rapid gwajin gwaji ne na in vitro don gano ingantacciyar hanyar gano ƙwayar cuta ta Respiratory Syncytial Virus (RSV) nucleoprotein antigens a cikin nasopharyngeal (NP) swab da samfuran aspirate na hanci, ta amfani da saurin immunochromatographic....
    Kara karantawa
  • Haɗu da Farawa a MEDICA, Düsseldorf Jamus!

    ●Lokaci: Nov 15-18th, 2021 ●Booth No: 3H14-2 Idan kuna son samun ƙarin bayani game da COVID-19 Total Solution da sauran reagents, barka da zuwa ziyarci rumfarmu a MEDICA.Farawa yana fatan saduwa da ku a nan!Idan kuna buƙatar tallafi ko ƙarin bayani tuntuɓe mu: Tel...
    Kara karantawa
  • KaibiLi COVID-19 Antigen akan PEI (Paul-Ehrlich-Institut) Jerin Amincewa!

    KaibiLi COVID-19 Antigen sami izinin PEI KaibiLi COVID-19 Antigen sami amincewar PEI.BfArM yana ba da jeri bisa ga jumla § 1 1 TestV na gwajin antigen don gano ƙwayoyin cuta na coronavirus SARS-CoV-2 kai tsaye, waɗanda masana'anta suka yi niyya don amfani da ƙwararru (&...
    Kara karantawa
  • Wace hanya za ku zaɓi don kare kanku don COVID-19?

    Farawa KaiBiLi COVID-19 Na'urar Gwajin Saurin Antigen da COVID-19 IgG/IgM Na'urar Gwajin Gaggawa sun sami takardar shedar NEMAN (CE-IVD).Tunda cutar ta COVID-19 ta kasance rikicin duniya, gwaje-gwaje tare da ƙwarewa da ƙayyadaddun bayanai suna da mahimmanci don ganowa da sarrafa majinyatan COVID-19.A halin yanzu, R...
    Kara karantawa
  • Farawa KaiBiLi COVID-19 kayan gwajin antigen (gwajin kai) ya sami izini a Austria

    Farawa KaiBiLi COVID-19 kayan gwajin antigen (gwajin kansa da sigar ƙwararrun) sun sami takaddun shaida na Austria.Kayan gwajin COVID-19 na Antigen na gaggawa wani makami ne mai kima a cikin maye gurbi na SARS-CoV-2 yana ci gaba da yaduwa.COVID-19 Antigen (Gwajin Kai) na iya gwada gwadawa, yi kuma ana iya samun sakamako.
    Kara karantawa